Members of Medigene management as expert speakers, Prof. Dolores Schendel, Chief Scientific Officer and Kirsty Crame, MD, Vice President, Clinical Strategy & Development Presentations and seminars ...

Extracellular vesicles (EVs) have marked a significant shift in cancer research, introducing novel approaches for early diagnosis, targeted therapeutic delivery, and the development of personalized ...

NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

TD Cowen analyst Tyler Van Buren maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report ... based on EyePoint Pharmaceuticals’ notable advancements in their clinical trials and ...

Three distinguished faculty members across the Purdue University system have been elected as 2024 American Physical Society (APS) Fellows, a prestigious recognition given to scientists who have made ...

Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has ...

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

Production tips from Crystal Bio, TriLink Biotechnologies, Ginkgo Bioworks, Quantoom Biosciences, and Parexel.

With an interim dean at the helm, the University of Texas at Tyler School of Medicine continues to make progress. From ...

Europe has been falling behind on clinical trials over the past decade as pharmaceutical companies shift their focus to the ...

As a surgeon and director of the Elkins Pancreas Center at Baylor College of Medicine, William Fisher, MD, knows how ...